Evidence map›Paper›PMID 41576094›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Caspase-3 cleaves and activates the NADase SARM1 to promote apoptosis, linking two cell death mechanisms.

Jianjin Shi, Ye Eun Kim, Nicolás José DeRuiter, Priyanka Kadav, Marc Tessier-Lavigne

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Direct activation of SARM1 by dsDNA is not supported by biochemical and cellular evidence.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianjin ShiDepartment of Biology, Stanford University, Stanford, CA 94305.
Ye Eun KimDepartment of Biology, Stanford University, Stanford, CA 94305.
Nicolás José DeRuiterDepartment of Biology, Stanford University, Stanford, CA 94305.
Priyanka KadavDepartment of Biology, Stanford University, Stanford, CA 94305.
Marc Tessier-LavigneDepartment of Biology, Stanford University, Stanford, CA 94305.

Funding

Damon Runyon Cancer Research Foundation (DRCRF) DRG: 2294-16Stanford University (SU) NA
6 · The paper itself

Abstract

Two major mechanisms of axon degeneration have been identified. The first, a caspase-dependent apoptotic pathway, is a major mediator of developmental axon degeneration triggered by loss of trophic support. The second, a caspase-independent pathway mediated by the sterile alpha and HEAT/Armadillo motif containing 1 (SARM1) NADase, was found in studies of injury-induced Wallerian degeneration; it is also implicated in degeneration associated with traumatic brain injury, as well as some neurodegenerative diseases and neuropathies. Recent studies suggest that SARM1 functions as a metabolic sensor for the cellular nicotinamide mononucleotide/NAD+ ratio through its autoinhibitory armadillo repeats (ARM) domain. Here, we show a tight link between apoptotic and SARM1-dependent degeneration by demonstrating that SARM1 is activated during and contributes to apoptosis in neuroblastoma cells, macrophages, and T cells. Mechanistically, the key apoptotic protease caspase-3 cleaves SARM1 within its ARM domain, relieving its autoinhibition and activating its NAD+ hydrolase activity. Using a knock-in (KI) mouse model with a SARM1 mutation that prevents caspase-3 cleavage, we show that apoptosis promotion by SARM1 in macrophages and T cells requires its cleavage, whereas in neurons deprived of trophic support, activation of SARM1 occurs both with and without cleavage. Our study identifies a central role for SARM1 in apoptosis in some cells that is mediated by SARM1 activation through caspase-3 cleavage; it provides a model for dissecting the contributions of the two modes of SARM1 activation in different cellular contexts; and it has implications for the selection of ortho- versus allosteric SARM1 inhibitors for treating neurodegenerative diseases.

Indexed as

ApoptosisArmadillo Domain ProteinsCaspase 3Cytoskeletal ProteinsAnimalsAxonsCell Line, TumorHumansMacrophagesMiceArmadillo Domain ProteinsCaspase 3Cytoskeletal ProteinsSARM1 protein, humanSARM1 protein, mouseapoptosisaxon degenerationcaspaseSARM1

Identifiers

PMID41576094
PMCPMC12846840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.